Sold as Ionamin. Every FDA application for this active ingredient: 1 branded and 2 generic.
As of Nov 16, 2026, FDA lists 3 applications for Phentermine Resin Complex (sold as Ionamin), first approved May 4, 1959, with 0 new uses approved and 0 published complete response letters.
| May 4, 1959 | IonaminNDA 11613 · New molecular entity | Ucb Inc | 18 | Discontinued |
| Jul 28, 2011 | Phentermine Resin ComplexANDA 40872 | Lannett Co Inc | 2 | Discontinued |
| — | Phentermine Resin 30ANDA 89120 | Quantum Pharmics | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA